Holmusk

Series-B+
holmusk.com Biotech & Healthcare New York, United States
Total Funding $21.5M
Latest Round Undisclosed Series-B+
Last Announced Feb 14, 2026
Investors 6 Backers
Decision Makers 6 Verified

About Holmusk

Holmusk is transforming neuropsychiatry with the field's largest clinical dataset, unlocking evidence for better decisions and improved outcomes.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters New York, United States
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website holmusk.com
Domain Registered Date Feb 10, 2015

Social & Network Presence

X / Twitter Profile @holmusk (336 followers) Created on Feb 2015
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  2. Capital Raise

    Raised $21,500,000 · Series-A

  3. Milestone

    X account created (@holmusk)

    336 followers

  4. Milestone

    Website domain registered

    holmusk.com

Investors & Backers

6
Health Catalyst Capital
Northwell Holdings
Novartis Venture Fund
Octave
Optum Ventures
Veradigm

Funding History

2 Rounds
Series-B+ · Feb 14, 2026
Series-A · May 18, 2020
$21,500,000 Source

Founders & Leadership

4

Eze Abosi

CGO

Work email & phone locked Unlock →

Nawal Roy

Founder

Work email & phone locked Unlock →

Péter Ferenczy

Software Engineer

Work email & phone locked Unlock →

Tony Tramontin

COO / CSO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts